Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
Yongxi Zhang, Shuyuan Liu, Tiesuo Zhao, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 150
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases
Pai‐Chi Teng, Yanwen Liang, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10592-10592
Open Access | Times Cited: 112
The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma
Lifang Ma, Xiangfei Xue, Xiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 71
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
Haisheng Yu, Jing Liu, Xia Bu, et al.
Cell chemical biology (2023) Vol. 31, Iss. 4, pp. 776-791.e7
Open Access | Times Cited: 34
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research
Na Song, Kai Cui, Ke Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome
Yi Chen, Yuling Wu, Linjie Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 19
Cancer-associated fibroblasts promote migration and invasion of non-small cell lung cancer cells via METTL3-mediated RAC3 m6A modification
Mengmeng Chen, Qicheng Zhang, Sijia Zheng, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 5, pp. 1616-1632
Open Access | Times Cited: 18
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications
Xiaojuan Su, Yi Feng, Yi Qu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1121-1136
Open Access | Times Cited: 7
Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Baishuang Yang, Qiong Chen
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 38
The molecular mechanism of METTL3 promoting the malignant progression of lung cancer
Chao Ma, Ruijie Ma, Kang Hu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression
Liu Zhang, Xiangyu Wang, Wenqiang Che, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14215-14226
Open Access | Times Cited: 22
Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m6A Methylation of COL10A1
Yuchan Li, Xiaoxue Li, Muwen Deng, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 21
Research progress on N6-adenosylate methylation RNA modification in heart failure remodeling
Yiqing Yang, Mbikyo B Muisha, Junzhe Zhang, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 4, pp. 340-348
Open Access | Times Cited: 19
METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2
Shu Zhao, Peng Song, Gang Zhou, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 8, pp. 1094-1104
Closed Access | Times Cited: 11
Targeting m6A RNA Modification in Tumor Therapeutics
Zhenwei Mao, Min Li, Shengjun Wang
Current Oncology (2025) Vol. 32, Iss. 3, pp. 159-159
Open Access
METTL3 Affects Spinal Cord Neuronal Apoptosis by Regulating Bcl-2 m6A Modifications After Spinal Cord Injury
Shengyu Guo, Taotao Lin, Gang Chen, et al.
Neurospine (2023) Vol. 20, Iss. 2, pp. 623-636
Open Access | Times Cited: 10
RNA modifications in pulmonary diseases
Weiwei Qian, Lvying Yang, Tianlong Li, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 3
COL1A1, mediated by m6A methylation of METTL3, facilitates oral squamous cell carcinoma cell growth and metastasis
Ruya Lv, Yao Yao, Jingjing Dong, et al.
Odontology (2024)
Closed Access | Times Cited: 3
Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: From basics to therapeutics
Fen-Sheng Qiu, Jiaqi He, Yu-Sen Zhong, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability
Ying Ji, Qing Zhao, Wei Feng, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5582-5582
Open Access | Times Cited: 15
YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer
Xifan Wang, Yu’an Hu, Xiaoqing Li, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 3, pp. 1247-1257
Open Access | Times Cited: 9
METTL3 promotes Non-Small-Cell Lung Cancer Growth and Metastasis by Inhibiting FDX1 Through Copper Death-Associated Pri-miR-21-5p Maturation
Shuai Qian, Jun Liu, Wenliang Liao, et al.
Epigenomics (2023) Vol. 15, Iss. 23, pp. 1237-1255
Closed Access | Times Cited: 8
Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression
Fang Yang, Weiqi Yuan, Juan Li, et al.
Oncology Letters (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 19
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
Zhaolin Chen, Ying Hu, Le Jin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top